Immunoreactivity of progesterone receptor isoform B and nuclear factor kappa-B as biomarkers for recurrence of ovarian endometriomas

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 5, 2008, Pages 486.e1-486.e10

  Shen, Fanghua ^a   Wang, Yuedong ^c   Lu, Yuan ^a   Yuan, Lei ^a   Liu, Xishi ^a   Guo, Sun Wei ^b  

^a Hospital of Shanghai   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarker; endometriosis; intervention; nuclear factor kappa B; ovarian endometrioma; progesterone receptor isoform B; recurrence

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROGESTERONE RECEPTOR B; SYNAPTOTAGMIN I;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM TUMOR; FEMALE; GENETIC DIFFERENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

EID: 54949158862     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.04.040     Document Type: Article

References (36)

1. Farquhar C.M. Extracts from the "clinical evidence.". Endometriosis BMJ 320 (2000) 1449-1452
2. Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 16 (2004) 299-303
3. Evers J.L., et al. Management of recurrent endometriosis. In: Couinho E., Spinola P., and DeMoura L.H. (Eds). Progress in the management of endometriosis (1995), Partheon, London London, 291-7
4. Roberts C.P., and Rock J.A. The current staging system for endometriosis: does it help?. Obstet Gynecol Clin North Am 30 (2003) 115-132
5. Liu X., Yuan L., Shen F., Zhu Z., Jiang H., and Guo S.W. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol 109 (2007) 1411-1420
6. Yuan L., Shen F., Lu Y., Liu X., and Guo S.W. COX-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertil Steril (2008) [Epub ahead of print.]
7. Yamamoto K., Arakawa T., Ueda N., and Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270 (1995) 31315-31320
8. Guo S.W. Nuclear factor-kappaB (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?. Gynecol Obestet Invest 63 (2006) 71-97
9. Gonzalez-Ramos R., Donnez J., Defrère S., Leclercq I., Squifflet J., Lousse J.C., et al. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 13 (2007) 503-509
10. Exacoustos C., Zupi E., Carusotti C., Rinaldo D., Marconi D., Lanzi G., et al. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc 10 (2003) 378-382
11. Ota H., Igarashi S., Sasaki M., and Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16 (2001) 561-566
12. Breiman L., et al. Classification and regression trees. 1st ed (1984), Chapman & Hall/CRC, New York
13. Inhaka R., and Gentleman R.R. R: a language for data analysis and graphics. J Comput Graph Statist 5 (1996) 1923-1927
14. Chung G.G., Zerkowski M.P., Ghosh S., Camp R.L., and Rimm D.L. Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest 87 (2007) 662-669
15. Soderlund K., Skoog L., Fornander T., and Askmalm M.S. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer. Radiother Oncol 84 (2007) 242-251
16. O'Malley F.P., Thomson T., Julian J., Have C., Crosby R., Gelmon K., et al. HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab. Arch Pathol Lab Med 132 (2008) 61-65
17. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., and Bulun S.E. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85 (2000) 2897-2902
18. Dai D., Wolf D.M., Litman E.S., White M.J., and Leslie K.K. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 62 (2002) 881-886
19. Hardy D.B., Janowski B.A., Corey D.R., and Mendelson C.R. Progesterone receptor (PR) plays a major anti-inflammatory role in human myometrial cells by antagonism of nuclear facto-kappaB activation of cyclooxygenase 2 (COX-2) expression. Mol Endocrinol 2 (2006) 2724-2733
20. Wu Y., Shi X.R., and Guo S.W. The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells. Fertil Steril (2008) [Epub ahead of print]
21. Kalkhoven E., et al. Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem 271 (1996) 6217-6224
22. Wu Y., et al. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1 (2006) 106-111
23. Wren J.D., Wu Y., and Guo S.W. A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium. Hum Reprod 22 (2007) 2093-2102
24. Aggarwal B.B., and Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030 (2004) 434-441
25. Wu Y., and Guo S.W. Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. Gynecol Obstet Invest 62 (2006) 193-205
26. Wu Y., and Guo S.W. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol 137 (2008) 198-203
27. Wu Y., Starzinski-Powitz A., and Guo S.W. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci 14 (2007) 374-382
28. Wu Y., Halverson G., Basir Z., Strawn E., Yan P., and Guo S.W. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193 (2005) 371-380
29. Wu Y., Starzinski-Powitz A., and Guo S. Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril 90 (2008) 234-237
30. Wu Y., Strawn E., Basir Z., Halverson G., and Guo S.W. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87 (2007) 24-32
31. Chang S.P., and Ng H.T. A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis. Zhonghua Yi Xue Za Zhi (Taipei) 57 (1996) 431-437
32. Xue Q., Lin Z., Cheng Y.H., Huang C.C., Marsh E., Yin P., et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 77 (2007) 681-687
33. Xue Q., Lin Z., Yin P., Milad M.P., Cheng Y.H., Confino E., et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis. J Clin Endocrinol Metab 92 (2007) 3261-3267
34. Izawa M., Harada T., Taniguchi F., Ohama Y., Takenaka Y., and Terakawa N. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells. Fertil Steril 89 Suppl 5 (2008) 1390-1396
35. Wu Y., Kajdacsy-Balla A., Strawn E., Basir Z., Halverson G., Jailwala P., et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinol 147 (2006) 232-246
36. Wu Y., Strawn E., Basir Z., Wang Y., Halverson G., Jailwala P., et al. Genomic alterations in the ectopic and eutopic endometrium of women with endometriosis. Gynecol Obstet Invest 62 (2006) 148-159